Moderna, Inc. (MRNA)
NASDAQ · Healthcare
Moderna, Inc. Shareholder Equity 2016–2025
Moderna, Inc. annual/quarterly shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Moderna, Inc. shareholder equity for the quarter ending December 31, 2025 were 8.65B, a 20.65% decrease year-over-year.
- Moderna, Inc. shareholder equity for 2025 were 8.65B, a 20.65% decrease from 2024.
- Moderna, Inc. shareholder equity for 2024 were 10.90B, a 21.32% decrease from 2023.
- Moderna, Inc. shareholder equity for 2023 were 13.85B, a 27.55% decrease from 2022.
- Moderna, Inc. shareholder equity for 2022 were 19.12B.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Moderna, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $8,650 |
| 2024 | $10,901 |
| 2023 | $13,854 |
| 2022 | $19,123 |
| 2021 | $14,145 |
| 2020 | $2,561 |
| 2019 | $1,175 |
| 2018 | $1,530 |
| 2017 | $-551 |
| Moderna, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $8,650 |
| 2024-12-31 | $10,901 |
| 2023-12-31 | $13,854 |
| 2022-12-31 | $19,123 |
| 2021-12-31 | $14,145 |
| 2020-12-31 | $2,561 |
| 2019-12-31 | $1,175 |
| 2018-12-31 | $1,530 |
| 2017-12-31 | $-551 |
Moderna Inc. Shareholder Equity — FAQ
Moderna Inc. (MRNA) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MRNA's shareholder equity history?
The chart and table above show Moderna Inc.'s shareholder equity by year and by quarter, including the growth rate.